TSVT 2seventy bio, Inc: Accounting Value per Share

Graphic logo of 2seventy bio (TSVT)

Royalty rights from the first approved drugs provide 2seventy bio, Inc. (TSVT) with a stable passive income stream. This historical book value chart visualizes capital dynamics, where the value of 4.10 serves as the baseline indicator. Resilience to macro shocks guarantees demand for the therapy, while asset optimization around Abecma has stabilized the operating margin and reduced the company's costs.

TSVT: 2seventy Bio Net Asset Value per Share 07/04/2022 - 05/24/2025

2seventybio.com - analytical breakdowns and key metrics (TSVT)

- price and consensus price forecast:
Stock Quotes 2seventy Bio|TSVT - Price Target Chart
- market capitalization data:
Market Valuation 2seventy bio, Inc.|TSVT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share 2seventy bio|TSVT - Total Stockholders' Equity|Market Value to Book Value Ratio 2seventybio.com|TSVT - Total Business Assets
- debt and liquidity data:
Total Debt to Capital 2seventy bio, Inc.|TSVT - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity 2seventy bio|TSVT - Company Cumulative Debt|Debt to Book Capitalization Ratio 2seventy bio, Inc.
Fundamental company valuation:TSVT - 2seventy Bio
Flagship merchandise of 2seventy bio

Driven by strong pricing power in the CAR-T therapy segment and inelastic demand for Abecma, 2seventy bio, Inc. (TSVT) is accumulating significant technological assets. An analysis of the aggregate book value per share allows for an assessment of the issuer's net asset value minus all liabilities, which serves as a fundamental indicator of the business's real value and a capital buffer during market volatility.

Competitor analysis for 2seventy bio, Inc.

LEGN - Accounting Value per Share|Sana Corp (SANA) - Net Assets per Single Share|AUTL - Accounting Value per Share|ALLO (allogene.com) - Book Price of a Share|Net Assets per Single Share RNAC (Cartesian Therapeutics, Inc.)|Net Asset Value per Share CLLS|Net Assets per Single Share Caribou Bio CRBU|Equity per Share Instil Bio Inc (TIL)|Genenta Science - Book Value per Share|Century Tx - Accounting Value per Share|JSPR (Jasper Bio) - Net Assets per Single Share|SNTI: Net Asset Value per Share|adaptimmune.com (ADAP) - Net Assets per Single Share|CERO (CERo Therapeutics Holdings) - Net Assets per Single Share|Net Assets per Single Share TCRT (Alaunos Therapeutics Inc.)|Net Asset Value per Share Achilles Tx|CRGX: Book Value per Share|Book Value of One Share Poseida Therapeutics Inc PSTX|GRCL: Accounting Value per Share